Your Health, We Care
Unresectable or Metastatic MelanomaCobimetinib® is indicated for use in combination with vemurafenib for the treatment of adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations.
Histiocytic NeoplasmsCobimetinib® is indicated as monotherapy for the treatment of adult patients with histiocytic neoplasms.
FDA，2023.05
Cobimetinib (Cotellic) is an oral, highly selective MEK1/2 inhibitor. Cobimetinib reversibly inhibits the catalytic activity of MEK1 and MEK2, blocking the phosphorylation and acti···【more】
Article source：Lucius LaosRelease date：2026-09-29Recommended：161
This product is indicated for the treatment of adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations (in combination with vemurafenib), as···【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：170
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
